CHANGE IN RATINGS
downgraded at Oppenheimer:AHG was downgraded to Sell at Oppenheimer. Stock trading well above its average historical valuation. $19 price target.
downgraded at Goldman: Goldman is downgrading APC to Neutral from Buy following disappointing guidance. Cites concern about company's ability to execute on its production growth plan. Lowered target price to $53 from $62.
rated new Buy at Credit Suisse: Credit Suisse is initiating AVR with an Outperform rating. Says company trades at a discount to VSE and several catalysts should push shares higher. Sets $28 target price.
target price lowered at Goldman: Goldman is lowering its target price on COO to $54 from $62. Company reported 4Q results that were short of consensus. Maintained Neutral rating.
downgraded at Piper: Piper is downgrading COO to a market perform rating following poor Q4 result and drastic reduction in guidance. Target price cut to $47 from $72
estimates cut at Prudential: Prudential is cutting its 2007 estimates on COO by 60 cents to $2.56 a share following rough quarter. Target cut to $45.
Cowen & Company
downgraded at Credit Suisse: Credit Suisse is downgrading COWN to Neutral from Outperform based on valuation. Stock has essentially reached its target price.
downgraded at Bear: CSX was downgraded to Peer Perform at Bear Stearns. Stock is up 44% on the year, and trading within 6% of the $39 price target. Fourth quarter estimate also cut, because of lower volume trends.
downgraded at Credit Suisse:Credit Suisse is downgrading DTV to Underperform from Neutral. Sees challenging competitive environment and believes changing dynamics favors DISH more. Raised target price to $20 from $19.
downgraded at JP Morgan: MBI was downgraded from Overweight to Neutral at JP Morgan. Stock now looks fully valued, after its recent run. MBI once again trades back up around book value.
downgraded at AG Edwards: MU was downgraded from Hold to Sell at AG Edwards. Expect DRAM prices to correct in the next few months. Future annual growth may also drop to the single-digits.
Pharm. Product Dev.
estimates lowered at Jefferies: PPDI estimates lowered at Jefferies. Price target drops to $40.00 from $44.50. 2007 EPS estimates lowered to $1.50 from $1.60. Reiterates Buy rating.
downgraded at Credit Suisse: Credit Suisse is downgrading SPP to Neutral from Outperform based on valuation following a quick run. Shares are trading just below $17 target price.
downgraded at JP Morgan: TSN was downgraded from Neutral to Underweight at JP Morgan. Valuation call, especially while 2007 numbers are at risk if the chicken market does not recover.
STOCK COMMENTS / EPS CHANGES
target raised at Morgan Stanley: Morgan Stanley raises its price target on Apple Computer from $90 to $110, and raises 2007/2008 EPS estimates.
numbers lowered at Jefferies: ADCT numbers lowered at Jefferies. Price target drops to $15 from $16. 2007 EPS estimates lowered to $0.75 from $0.95. Reiterates Hold rating.
numbers lowered at UBS: ADCT numbers lowered at UBS. Price target drops to $15 from $16. 2007 EPS estimates lowered to $0.78 from $0.91. Reiterates Neutral rating.
estimates cut at Goldman: Goldman is cutting its 2007 estimates on CC by 5 cents to $1.40 based on impact of falling TV prices. Lowered target price to $29 from $30.
numbers drop at Jefferies: CLS numbers lowered at Jefferies. Price target drops to $8.25 from $10.50. 2007 EPS estimates lowered to $0.69 from $0.78. Reiterates Hold rating.
numbers raised at UBS: GE numbers raised at UBS. Price target lifts to $40 from $38 and bumps 2006 EPS estimates a penny to $1.98. Reiterates Neutral rating.
outlook lowered at Goldman: Goldman is lowering its 2007 EPS estimates on NUE after company reduced guidance. Lowered target price to $67 from $69.
estimates change at UBS: SAI estimates change at UBS. 2007 EPS estimates rise to $0.98 from $0.91. However, 2008 estimates drop to $0.86 from $0.91. Reiterates Neutral rating.